Home Search
hepa - search results
If you're not happy with the results, please do another search
Adding Auris Medical (EARS) $3.50 to Biotech Watch List.
Auris Medical soared 590% in one Week on Covid Related News on December 1st, 2020.
LIFT OFF...
Provention Bio (PRVB) Updates.
LATEST UPDATE July 13th, 2022, below.
(2021) We're getting way too many calls on...
The Buffett Indicator. Tighten Your Safety Belts..
GDP's $22 Trillion vs Total Stock Market Value (TMC) of $50 Trillion
How Does This Compute (hint,...
Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.
The 2021 Biotech Six Pack: Stocks We Expect to Double!
These are ideas #3 and #4 for the 'Biotech...
Make Hay While the Sun Shines. Up 6,400%.
Celcius (CELH) We're Up 6,400%. Alkaline Water (WTER) We're Up 12%.Dicerna (DRNA) We're Up 700%. Ready to Breakout?BioSig (BSGM) We Have...
Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.
Another Fatty Liver Idea. This Time a Play on Detecting Fatty Liver Non-Invasively. Heads Up. Nearing Resistance at $0.89.
Video: Okay, You Tested Positive for Corona, Now What?
https://youtu.be/vN30emwcNS4
Professor Roger Seheult,...
Fatty Liver? 15-25% of the US Population Has It. (Video)
Wait, what. Another Silent Epidemic?
Watch the video below. Presentation from Dr. Danielle Brandman (UCSF), a liver...
Hepion Pharma Doses First Patient in the ‘AMBITION’ Clinical Trial.
Hepion Pharmaceuticals Completes 75 mg CRV431 Dosing, Initiates 225 mg Dosing in Phase 2a 'AMBITION' Clinical Trial for NASH.
Newsletter: Institutional Analyst. And Yes, We Have Another Double.
1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3....